The DOI matches its Crossref record; 32 of the 32 references it cites were found in a registry or an index.
HIF-2α maintains an undifferentiated state in neural crest-like human neuroblastoma tumor-initiating cells
Open accessAbstract
High hypoxia-inducible factor-2α (HIF-2α) protein levels predict poor outcome in neuroblastoma, and hypoxia dedifferentiates cultured neuroblastoma cells toward a neural crest-like phenotype. Here, we identify HIF-2α as a marker of normoxic neural crest-like neuroblastoma tumor-initiating/stem cells (TICs) isolated from patient bone marrows. Knockdown of HIF-2α reduced VEGF expression and induced partial sympathetic neuronal differentiation when these TICs were grown in vitro under stem cell-promoting conditions. Xenograft tumors of HIF-2α-silenced cells were widely necrotic, poorly vascularized, and resembled the bulk of tumor cells in clinical neuroblastomas by expressing additional sympathetic neuronal markers, whereas control tumors were immature, well-vascularized, and stroma-rich. Thus, HIF-2α maintains an undifferentiated state of neuroblastoma TICs. Because low differentiation is associated with poor outcome and angiogenesis is crucial for tumor growth, HIF-2α is an attractive target for neuroblastoma therapy.
Overview
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
The cited source says what the claim attributes to it.
In the citing paper
“HIF-2α knockdown in glioblastoma and neuroblastoma results in poorly vascularized tumors (Li et al., 2009;Pietras et al., 2009).”
From Therapeutic targeting of hypoxia and hypoxia-inducible factors in cancer (2016) · cites this paper as Pietras et al., 2009
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Vandesompele, J., De Preter, K., Pattyn, F., Poppe, B., Van Roy, N., De Paepe, A., & Speleman, F. (2002) · Genome Biology · doi:10.1186/gb-2002-3-7-research0034 · Cited by 20,038
A Perivascular Niche for Brain Tumor Stem Cells
Calabrese, C. R., Poppleton, H., Koçak, M., Hogg, T. L., Fuller, C. E., Hamner, J. B., Oh, E. Y., Gaber, M. W., Finklestein, D., Allen, M., et al. (2007) · Cancer Cell · doi:10.1016/j.ccr.2006.11.020 · Cited by 2,253
Hypoxia-inducible factors regulate tumorigenic capacity of glioma stem cells
Li, Z., Bao, S., Wu, Q., Wang, H., Eyler, C., Sathornsumetee, S., Shi, Q., Cao, Y., Lathia, J., McLendon, R. E., et al. (2009) · Cancer Cell · doi:10.1016/j.ccr.2009.03.018 · Cited by 1,354
Stem Cell–like Glioma Cells Promote Tumor Angiogenesis through Vascular Endothelial Growth Factor
Bao, S., Wu, Q., Sathornsumetee, S., Hao, Y., Li, Z., Hjelmeland, A. B., Shi, Q., McLendon, R. E., Bigner, D. D., & Rich, J. N. (2006) · Cancer Research · doi:10.1158/0008-5472.can-06-1010 · Cited by 1,347
Hypoxia-Inducible Factors, Stem Cells, and Cancer
Keith, B., & Simon, M. C. (2007) · Cell · doi:10.1016/j.cell.2007.04.019 · Cited by 1,179
Hypoxia requires Notch signaling to maintain the undifferentiated cell state
Gustafsson, M. V., Zheng, X., Pereira, T., Gradin, K., Jin, S., Lundkvist, J., Ruas, J. L., Poellinger, L., Lendahl, U., & Bondesson, M. (2005) · Developmental Cell · doi:10.1016/j.devcel.2005.09.010 · Cited by 1,109
Appelhoff, R. J., Tian, Y.-M., Raval, R. R., Turley, H., Harris, A. L., Pugh, C. W., Ratcliffe, P. J., & Gleadle, J. M. (2004) · Journal of Biological Chemistry · doi:10.1074/jbc.m406026200 · Cited by 1,108
Covello, K. L., Kehler, J., Yu, H., Gordan, J. D., Arsham, A. M., Hu, C., Labosky, P. A., Simon, M. C., & Keith, B. (2006) · Genes & Development · doi:10.1101/gad.1399906 · Cited by 850
Ishibashi, M., Ang, S., Shiota, K., Nakanishi, S., Kageyama, R., & Guillemot, F. (1995) · Genes & Development · doi:10.1101/gad.9.24.3136 · Cited by 767
Holmquist-Mengelbier, L., Fredlund, E., Löfstedt, T., Noguera, R., Navarro, S., Nilsson, H., Pietras, A., Vallon-Christersson, J., Borg, Å., Gradin, K., et al. (2006) · Cancer Cell · doi:10.1016/j.ccr.2006.08.026 · Cited by 735
Self-citation
Cited by
Sorted by citations
Items 101–135 of 135
Wnt/BMP Mediated Metabolic Reprogramming Preserves Multipotency of Neural Crest-Like Stem Cells
Mehrotra, P., Ikhapoh, I. A., Lei, P., Tseropoulos, G., Zhang, Y., Wang, J., Liu, S., Bronner-Fraser, M. E., & Andreadis, S. T. (2023) · Stem Cells · doi:10.1093/stmcls/sxad001 · Cited by 11
MicroRNAs as prospective biomarkers, therapeutic targets and pharmaceuticals in neuroblastoma
Андреева, Н. А., Usman, N. Y., & Druy, A. E. (2022) · Molecular Biology Reports · doi:10.1007/s11033-022-08137-y · Cited by 11
Hemangioblastoma Stromal Cells Show Committed Stem Cell Phenotype
Welten, C. M., Keats, E. C., Ang, L.-C., & Khan, Z. A. (2012) · Canadian Journal of Neurological Sciences / Journal Canadien des Sciences Neurologiques · doi:10.1017/s0317167100015675 · Cited by 10
Epithelial-Mesenchymal Transition in Tumor Microenvironment Induced by Hypoxia
Eskiizmir, G., & Özgür, E. (2018) · IntechOpen eBooks · doi:10.5772/intechopen.78717 · Cited by 11
Tumor-Initiating Cells in Childhood Neuroblastoma—Letter
Mohlin, S., Pietras, A., Wigerup, C., Øra, I., Andäng, M., Nilsson, K., Olofsson, T., Gisselsson, D., & Påhlman, S. (2012) · Cancer Research · doi:10.1158/0008-5472.can-11-1761 · Cited by 10
Self-citationBaudel, M. A. S. M., Rae, M. T., Darlison, M. G., Poole, A. V., & Fraser, J. A. (2017) · PLoS ONE · doi:10.1371/journal.pone.0185664 · Cited by 10
Natural killer cell-based therapies in neuroblastoma
Ghasempour, A., Mohseni, R., Sharif, P. M., & Hamidieh, A. A. (2024) · Cellular Immunology · doi:10.1016/j.cellimm.2024.104898 · Cited by 8
Westerlund, I., Shi, Y., & Holmberg, J. (2018) · Biochemical and Biophysical Research Communications · doi:10.1016/j.bbrc.2018.12.076 · Cited by 8
New prognostic markers in neuroblastoma
Navarro, S., Piqueras, M., Villamón, E., Yáñez, Y., Balaguer, J., Cañete, A., & Noguera, R. (2012) · Expert Opinion on Medical Diagnostics · doi:10.1517/17530059.2012.704018 · Cited by 7
Self-citationHIF and MYC signaling in adrenal neoplasms of the neural crest: implications for pediatrics
Bechmann, N., Westermann, F., & Eisenhofer, G. (2023) · Frontiers in Endocrinology · doi:10.3389/fendo.2023.1022192 · Cited by 7
Jögi, A. (2015) · Springer eBooks · doi:10.1007/978-3-7091-1824-5_4 · Cited by 7
The Role of Cancer Stem Cells in Tumor Radioresistance
Kurth, I., Peitzsch, C., Baumann, M. A., & Dubrovska, A. (2014) · Wiley eBooks · doi:10.1002/9781118356203.ch35 · Cited by 7
Kasemeier‐Kulesa, J. C., Spengler, J. A., Muolo, C. E., Morrison, J. A., Woolley, T. E., Schnell, S. D., & Kulesa, P. M. (2021) · Developmental Biology · doi:10.1016/j.ydbio.2021.08.007 · Cited by 6
Yang, L., Zheng, J., Xu, T., & Xiao, X. (2013) · Oncology Reports · doi:10.3892/or.2013.2356 · Cited by 6
Westerlund, I., Shi, Y., Toskas, K., Fell, S. M., Li, S., Södersten, E., Schlisio, S., & Holmberg, J. (2017) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.1718429115 · Cited by 5
Hypoxia Promotes an Adrenergic to Mesenchymal Transcriptional Program Transition in Neuroblastoma
Chaves, G. S., Chennakesavalu, M., Moore, K., Adams, H., Chittenden, C., Wilkinson, E., Vayani, O. R., Kaufman, M. E., Chlenski, A., He, C., et al. (2026) · Clinical and Translational Science · doi:10.1111/cts.70508 · Cited by 3
Juan, M., Buerl, C., Lpez, C. M. R., Satu, P., Navarro, S., & Barettino, D. (2012) · InTech eBooks · doi:10.5772/27102 · Cited by 3
Self-citationSerum hypoxia‐inducible factor‐2: A candidate prognostic biomarker for laryngeal cancer
Eskiizmir, G., Calibasi‐Kocal, G., Uysal, T., Ellıdokuz, H., & Baspinar, Y. (2021) · Clinical Otolaryngology · doi:10.1111/coa.13789 · Cited by 3
Buczacki, S. J. A. (2015) · Elsevier eBooks · doi:10.1016/b978-0-12-394447-4.30119-5 · Cited by 3
Darvish-Damavandi, M., Zhou, Y., & Buczacki, S. J. A. (2022) · Elsevier eBooks · doi:10.1016/b978-0-12-821618-7.00076-6 · Cited by 3
Svensson, K. J. (2012) · Lund University Publications (Lund University) · Cited by 2
Yuan, J., Maitra, S., Antoniou, E., Zhu, J., Li, W., Demirel, I. S., Toskas, K., Martinez, I. L., Ozcimen, L., Lindehell, H., et al. (2025) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.2516922122 · Cited by 1
Stem Cell Pathways in Brain Tumors
Lathia, J. D., Li, M., Bonnamain, V., & Rich, J. N. (2012) · Springer eBooks · doi:10.1007/978-1-4614-3801-4_13 · Cited by 1
Tumor-Initiating Cells in Childhood Neuroblastoma—Response
Hansford, L. M., & Kaplan, D. R. (2012) · Cancer Research · doi:10.1158/0008-5472.can-11-3548 · Cited by 1
Self-citationThe role of Notch signaling in cancer and metastasis
Mutvei, A. P. (2014) · Figshare · Cited by 1
Cancer-associated HIF-2α impacts trunk neural crest stemnessPreprint
Mohlin, S., Persson, C. U., Fredlund, E., Monni, E., Lindvall, J. M., Kokaia, Z., Hammarlund, E. U., & Bronner-Fraser, M. E. (2020) · bioRxiv (Cold Spring Harbor Laboratory) · doi:10.1101/2020.01.22.915199 · Cited by 1
Self-citationCancer Stem Cells: Paradigm Shifting or Perishing Concept?
Pazhanisamy, S. K., & Chan, K. S. (2011) · Springer eBooks · doi:10.1007/978-94-007-2801-1_7
Endothelial and Accessory Cell Interactions in Neuroblastoma Tumor Microenvironment
Gershan, J. A., Chan, A. M.-L., Chrzanowska‐Wodnicka, M., Johnson, B. D., Robert, Q., & Ramchandr, R. (2013) · InTech eBooks · doi:10.5772/55486 · Cited by 1
Fardin, P., Barla, A., Mosci, S., Rosasco, L., Verri, A., Versteeg, R., Caron, H. N., Molenaar, J. J., Øra, I., Eva, A., et al. (2010)
Bodempudi, V., Hergert, P. J., Smith, K. A., Hong, X., Herrera, J., Peterson, M. S., Khalil, W., Kahm, J., Bitterman, P. B., & Henke, C. A. (2014)
Role of Stemness Factors in Neuroblastoma
Stafman, L. L., Aye, J. M., & Beierle, E. A. (2019) · Elsevier eBooks · doi:10.1016/b978-0-12-812005-7.00011-4
Eisenhofer, G., Pamporaki, C., Kuhlen, M., & Redlich, A. (2023) · Springer eBooks · doi:10.1007/978-3-031-37275-9_6
Role of VDAC1 hypoxic form, VDAC1-∆C, in the expression of primary cilia and tumor progression
Fabbri, L. (2019) · theses.fr (ABES) · doi:10.70675/7a53239dzc652z4ea4z8b95z4a71961c83b4
Impact du ciblage du domaine de liaison de HIF-1α avec HIF-1β sur le paysage immunitaire du mélanome
Lequeux, A. (2020) · theses.fr (ABES) · doi:10.70675/a29d12dbz79c1z4d37za978z2e2319131c82
Metadata
- Authors
- Pietras, A., Hansford, L. M., Johnsson, A. S., Bridges, E., Sjölund, J., Gisselsson, D., Rehn, M., Beckman, S., Noguera, R., Navarro, S., Cammenga, J., Fredlund, E., Kaplan, D. R., & Påhlman, S.
- Affiliations
- Lund University (SE)
- University of Toronto (CA)
- Departments of cClinical Genetics and
- Universitat de València (ES)
- ORCID
- Venue
- Proceedings of the National Academy of Sciences
- Publisher
- National Academy of Sciences
- Published
- 2009-09-29
- Volume
- 106
- Issue
- 39
- Pages
- 16805-16810
- ISSN
- 0027-8424 (ISSN-L)
- 1091-6490
- PMC
- PMC2745331
- OpenAlex
- W1967063990
- Cited by
- 135
- References
- 32
- Citations by year
- 2026: 1 · 2025: 2 · 2024: 2 · 2023: 4 · 2022: 5 · 2021: 6 · 2020: 10 · 2019: 5 · 2018: 11 · 2017: 13 · 2016: 9 · 2015: 8 · 2014: 11 · 2013: 10 · 2012: 14
- FWCI
- 8.11
- Type
- journal article
- Language
- en
- Open access
- green
- www.ncbi.nlm.nih.gov
- Locations
- Proceedings of the National Academy of Sciences (publishedVersion)
- PubMed Central (publishedVersion)
- PubMed (publishedVersion)
- Lund University Publications (Lund University) (submittedVersion)
- Topics
- Health Sciences › Medicine › Oncology › Neuroblastoma Research and Treatments
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Cancer Research › Cancer, Hypoxia, and Metabolism
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Molecular Biology › Angiogenesis and VEGF in Cancer
- Keywords
- HIF-2α, neuroblastoma, cancer stem cells, neural crest-like cells, hypoxia, neuronal differentiation, vascular endothelial growth factor, tumor angiogenesis, tumor necrosis, bone marrow, stem cell niche, therapeutic target
- MeSH terms
- Endothelial PAS Domain-Containing Protein 1, Animals, Cell Differentiation, Female, Humans, Mice, Nude, Neural Crest, Neuroblastoma, Down-Regulation, Cell Hypoxia, Vascular Endothelial Growth Factors, Cell Line, Tumor, Mice, Basic Helix-Loop-Helix Proteins, Basic Helix-Loop-Helix Transcription Factors
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review